Navigating laboratory investigations for an accurate assessment of community-acquired pneumonia: Case report
Abstract
According to recent findings, demographic characteristics, seasonal fluctuations, and geographic regions are factors for the community-acquired pneumonia. Community acquired pneumonia is a non-hospital acquired lung parenchymal infection caused by gram-negative bacteria “Pseudomonas aeruginosa” which is transmitted through inhaling infected droplets. Here, we are reporting a case of geriatric patient with chief complaints of cough in the past 20 days, shortness of breath, tachycardia, tachypnoea, fever, and chest pain from 10 days. physician was suggested go for further investigations and lab reports like complete blood picture count, ESR test, sputum culture test and radiographic findings like Chest X-ray, chest computed tomography. Standard treatment includes antibiotics like Levofloxacin, Azithromycin and antihypertensive like Telmisartan, and mucolytics like Ambroxol syrup and other medications like N-Acetyl Cysteine, levocetirizine. If early diagnosis and early treatment were initiated, then the progression of diseases would have been stopped and then the Patient was discharged with stable condition, but she must come for the follow-up sessions like OP sessions. If the patient follows the life-style modifications and precautions like practice good hygiene, take enough rest, consume healthy diet, the quality of life will be improved.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.